Francesca Messa

735 citations

28 papers · 255 indexed · h-index 7

Co-authors: Daniela Cilloni Giuseppe Saglio Enrico Gottardi Milena Fava M Bertini Carlo Marinone Andrea Gallamini Dario Ferrero
Topics: Chronic Myeloid Leukemia Treatments (15 papers)Acute Myeloid Leukemia Research (9 papers)Chronic Lymphocytic Leukemia Research (8 papers)
Cited by: Hematology Genetics Molecular Biology
Journals: Journal of Clinical Oncology Blood Cancer
Partner nations: Italy United States United Kingdom

In The Last Decade

Francesca Messa

27 papers receiving 250 citations

Peers

Countries citing papers authored by Francesca Messa

Since Specialization

Citations

This map shows the geographic impact of Francesca Messa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Messa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Messa more than expected).

Fields of papers citing papers by Francesca Messa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Messa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Messa. The network helps show where Francesca Messa may publish in the future.

Co-authorship network of co-authors of Francesca Messa

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Messa. A scholar is included among the top collaborators of Francesca Messa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Messa. Francesca Messa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A new BCR-ABL1 Drosophila model as a powerful tool to elucidate the pathogenesis and progression of chronic myeloid leukemia 2018 ·Haematologica ·Roberto Bernardoni,Giorgia Giordani,(unknown),(unknown),Francesca Messa,Monica Pradotto,Valentina Rosso,Enrico Bracco,Angela Giangrande,Giovanni Perini,Giuseppe Saglio,Daniela Cilloni	8
2	Abstract 251: Disabled gene is involved in CML progression and its expression level at diagnosis can predict major molecular response (MMR) to imatinib therapy 2010 ·Cancer Research ·Francesca Arruga,Francesca Messa,Monica Pradotto,Roberto Bernardoni,Enrico Bracco,Sonia Carturan,(unknown),Emanuela Messa,(unknown),Antonia Rotolo,E. Greco,Ilaria Iacobucci,(unknown),Valentina Gaidano,Fabrizio Pane,Thea Kalebic,Giovanni Martinelli,Michele Baccarani,Giuseppe Saglio,Daniela Cilloni	1
3	HYPEREOSINOPHILIC SYNDROME IN CHILDHOOD: Clinical and Molecular Features of Two Cases 2009 ·Pediatric Hematology and Oncology ·Piero Farruggia,Paolo D’Angelo,Antonio Acquaviva,Antonino Trizzino,Fábio C. Tucci,Daniela Cilloni,Francesca Messa,Alfonso D’Ambrosio,Maurizio Aricò	6
4	Disabled Gene Is Involved in CML Progression and Its Expression Level at Diagnosis Can Predict Major Molecular Response (MMR) to Imatinib Therapy. 2009 ·Blood ·Daniela Cilloni,Francesca Arruga,Francesca Messa,Monica Pradotto,Enrico Bracco,Sonia Carturan,(unknown),Emanuela Messa,Antonia Rotolo,E. Greco,Ilaria Iacobucci,Roberto Bernardoni,Fabrizio Pane,Thea Kalebic,Giovanni Martinelli,Michele Baccarani,Giuseppe Saglio	1
5	Foxo Transcription Factor Activity Is Retained in Quiescent Chronic Myeloid Leukaemia Stem Cells and Activated by Tyrosine Kinase Inhibitors to Mediate “induced-quiescence” in More Mature progenitors. 2009 ·Blood ·Daniela Cilloni,Francesca Pellicano,(unknown),Cristina Panuzzo,Francesca Messa,Brian J.P. Huntly,Elaine Allan,Francesca Arruga,Enrico Bracco,Giuseppe Saglio,Tessa L. Holyoake	3
6	Identification of Rab5 as a Gene Involved in Chronic Myeloid Leukemia (CML) Progression. 2009 ·Blood ·Daniela Cilloni,Monica Pradotto,Francesca Messa,Francesca Arruga,Enrico Bracco,Sonia Carturan,(unknown),Emanuela Messa,Antonia Rotolo,E. Greco,Ilaria Iacobucci,Thea Kalebic,Roberto Bernardoni,Fabrizio Pane,Giovanni Martinelli,Michele Baccarani,Giuseppe Saglio	1
7	Detection of Humoral Immune Responses against WT1 Antigen in Patients Affected by Different Hematological Malignancies 2008 ·Acta Haematologica ·(unknown),Ilaria Defilippi,Sonia Carturan,Antonella Roetto,Francesca Messa,Francesca Arruga,Emanuela Messa,Antonia Rotolo,Ilaria Iacobucci,Enrico Bracco,Giuseppe Saglio,Daniela Cilloni	1
8	Imatinib Induced Re-Activation of FoxO3 Transcription Factor in CML Is Responsible for the Induction of a Quiescent Status of CD34 Leukaemic Progenitor Cells. 2008 ·Blood ·Daniela Cilloni,Cristina Panuzzo,Francesca Messa,Francesca Arruga,Enrico Bracco,Roberto Bernardoni,Sonia Carturan,Marisa Pautasso,Emanuela Messa,Alessandro Morotti,Monica Pradotto,Ilaria Iacobucci,Thea Kalebic,Giovanni Martinelli,Giuseppe Saglio	1
9	Deferasirox Is the Only Iron Chelator Acting as a Potent NF-KB Inhibitor in Myelodysplastic Syndromes 2008 ·Blood ·Emanuela Messa,Ilaria Defilippi,Antonella Roetto,Francesca Messa,Francesca Arruga,Sonia Carturan,Valentina Rosso,Enrico Bracco,Daniela Cilloni,Giuseppe Saglio	8
10	Single Base Pair Mutation Detection by PNA Direct PCR Clamping: Application to Bcr-Abl T315I Mutation 2008 ·Blood ·Enrico Bracco,(unknown),Marco Lo Iacono,Francesca Arruga,Valentina Rosso,(unknown),(unknown),Sonia Carturan,Francesca Messa,Ilaria Defilippi,Cristina Panuzzo,(unknown),Emanuela Messa,Antonia Rotolo,Alessandro Morotti,Alessandra Balbo,(unknown),(unknown),Daniela Cilloni,Giuseppe Saglio	1
11	Nck Beta Adapter Protein Coordinates Bcr-Abl/Sam68 Intermolecular Interaction. 2008 ·Blood ·Enrico Bracco,(unknown),Valentina Rosso,(unknown),Francesca Arruga,Sonia Carturan,Francesca Messa,Ilaria Defilippi,Cristina Panuzzo,(unknown),Emanuela Messa,Antonia Rotolo,(unknown),Alessandro Morotti,Alessandra Balbo,Ilaria Iacobucci,Giovanni Martinelli,Daniela Cilloni,Giuseppe Saglio	2
12	EphA3 Kinase Is Constitutively Activated in Chronic Myeloid Leukaemia during Progression to Accelerated and Blast Crisis and It Could Represent a New Molecular Target. 2008 ·Blood ·Daniela Cilloni,Francesca Arruga,Sonia Carturan,Francesca Messa,Monica Pradotto,Ilaria Defilippi,Marisa Pautasso,Ilaria Iacobucci,Giovanni Martinelli,Enrico Bracco,Thea Kalebic,Martin Lackmann,Giuseppe Saglio	3
13	FoxO Transcription Factor Is Delocalized and Inactivated in Acute Myeloid Leukaemia Patients. 2007 ·Blood ·Daniela Cilloni,Cristina Panuzzo,Francesca Messa,Francesca Arruga,(unknown),Emanuela Messa,Sonia Carturan,Ilaria Defilippi,Ilaria Iacobucci,Valentina Rosso,Giovanni Martinelli,Enrico Bracco,Giuseppe Saglio	1
14	Valproate enhances imatinib‐induced growth arrest and apoptosis in chronic myeloid leukemia cells 2006 ·Cancer ·Alessandro Morotti,Daniela Cilloni,Francesca Messa,Francesca Arruga,Ilaria Defilippi,Sonia Carturan,(unknown),Valentina Rosso,Annalisa Chiarenza,(unknown),Angelo Guerrasio,Riccardo Taulli,Enrico Bracco,Marisa Pautasso,(unknown),Enrico Gottardi,Giuseppe Saglio	30
15	Genetic Abnormalities as Targets for Molecular Therapies in Myelodysplastic Syndromes 2006 ·Annals of the New York Academy of Sciences ·Daniela Cilloni,Emanuela Messa,Francesca Messa,Sonia Carturan,Ilaria Defilippi,Francesca Arruga,Valentina Rosso,(unknown),Enrico Bracco,(unknown),Giuseppe Saglio	7
16	FIP1L1-PDGFRalpha Positive Hypereosinophilic Syndrome (HES). The Response to Imatinib (IM) Is Durable. A Report of 21 Patients with a Follow-Up of 12 to 67 Months. 2006 ·Blood ·Michela Rondoni,Emanuela Ottaviani,Pier Paolo Piccaluga,Stefania Paolini,Serena Merante,Daniela Cilloni,Michele Malagola,(unknown),Tiziana Grafone,Francesca Messa,Francesco Buccisano,Mario Tiribelli,Fabrizio Pane,Giuseppe Saglio,Giovanni Martinelli,Michele Baccarani	3
17	Myelodysplastic Syndromes 2004 ·Annals of the New York Academy of Sciences ·(unknown),Francesca Messa,Sonia Carturan,Francesca Arruga,Ilaria Defilippi,Emanuela Messa,Enrico Gottardi,Giuseppe Saglio	5
18	Sensitivity to imatinib therapy may be predicted by testing Wilms tumor gene expression and colony growth after a short in vitro incubation 2004 ·Cancer ·Daniela Cilloni,Francesca Messa,Enrico Gottardi,Milena Fava,Francesca Arruga,Ilaria Defilippi,Sonia Carturan,Emanuela Messa,Alessandro Morotti,Emilia Giugliano,Giovanna Rege‐Cambrin,Daniele Alberti,Michele Baccarani,Giuseppe Saglio	26
19	The IKK Inhibitor PS1145 Allows to Overcome Imatinib Resistance. 2004 ·Blood ·Daniela Cilloni,Francesca Messa,Francesca Arruga,Ilaria Defilippi,Alessandro Morotti,Emanuela Messa,Sonia Carturan,Milena Fava,Enrico Gottardi,Giovanni Martinelli,Michele Baccarani,Giuseppe Saglio	1
20	Down-modulation of the C/EBPα transcription factor in core binding factor acute myeloid leukemias 2003 ·Blood ·Daniela Cilloni,Sonia Carturan,Enrico Gottardi,Francesca Messa,Emanuela Messa,Milena Fava,Daniela Diverio,Angelo Guerrasio,Francesco Lo‐Coco,Giuseppe Saglio	26

About Francesca Messa

Francesca Messa is a scholar working on Hematology, Genetics and Molecular Biology, having authored 28 papers that have together received 255 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (15 papers), Acute Myeloid Leukemia Research (9 papers) and Chronic Lymphocytic Leukemia Research (8 papers). The work is most often cited by research in Hematology (166 citations), Genetics (67 citations) and Molecular Biology (152 citations). Francesca Messa has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Daniela Cilloni, Giuseppe Saglio, Enrico Gottardi, Milena Fava, M Bertini, Carlo Marinone, Andrea Gallamini, Dario Ferrero, Alessandro Levis and Patrizia Scaravaglio. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact